ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
0,0425
0,00
( 0,00% )
Aktualisiert: 10:14:41
Echtzeitdaten

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
0,0425
Gebot
0,04
Fragen
0,045
Volumen
30.000
0,0425 Tagesbereich 0,0425
0,0135 52-Wochen-Bereich 0,0938
Marktkapitalisierung
Handelsende
0,0425
Handelsbeginn
0,0425
Letzte Trade
30000
@
0.0425
Letzter Handelszeitpunkt
10:14:38
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
68.693
Ausgegebene Aktien
256.454.505
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-6,06
Gewinn pro Aktie (EPS)
-0,01
Erlöse
35k
Nettogewinn
-2,54M

Über Sirona Biochem Corp

Sektor
Unit Inv Tr, Closed-end Mgmt
Branche
Pharmaceutical Preparations
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2006
Sirona Biochem Corp is listed in the Unit Inv Tr, Closed-end Mgmt sector of the Tradegate (DE) with ticker ZSB. The last closing price for Sirona Biochem was 0,04 €. Over the last year, Sirona Biochem shares have traded in a share price range of 0,0135 € to 0,0938 €.

Sirona Biochem currently has 256.454.505 shares in issue. The market capitalisation of Sirona Biochem is 10,90 € million. Sirona Biochem has a price to earnings ratio (PE ratio) of -6.06.

ZSB Neueste Nachrichten

Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology

VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) is proud to announce the publication of a pivotal research article in the prestigious...

SIRONA BIOCHEM Poised for Profitability in 2025 with Anti-Aging Product Rollout

VANCOUVER, British Columbia, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) provides the following update: Dear...

GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient...

Sirona Biochem Engages Stonegate Healthcare Partners

VANCOUVER, British Columbia, May 07, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) has announced a partnership with Stonegate Healthcare Partners. Stonegate...

SIRONA BIOCHEM Corporate Update April 2024

VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) provides the following update: Dear...

Sirona Biochem Announces Close of Private Placement

VANCOUVER, British Columbia, April 04, 2024 (GLOBE NEWSWIRE) -- Vancouver, British Columbia – April 4, 2024 – Sirona Biochem Corp. (TSX-V: SBM) (Frankfurt: ZSB) (“Sirona”) has closed its private...

Sirona Biochem Announces 2023 Annual Meeting Results

VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona”) announces the voting results from its Annual General Meeting...

Sirona Biochem Receives Commercial-Grade GlycoProteMim Based Anti-Aging Serum Formulations

VANCOUVER, British Columbia, March 13, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announces a significant achievement in its...

Sirona Biochem Announces Plans for Commercial Launch of GlycoProteMim™ in Early 2025

VANCOUVER, British Columbia, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (US-OTC: SRBCF), also known as Sirona, is excited to share a new milestone in its...

Sirona Biochem Provides Update on Loan

VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) announce that, further to its news release on...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0065-13.26530612240.0490.0490.0365481100.0476799DE
40.00051.190476190480.0420.050.0365941590.04592578DE
120.00051.190476190480.0420.0590.0345686930.04606583DE
260.0037.594936708860.03950.06450.0135840690.03925529DE
52-0.0127-23.00724637680.05520.09380.01351328110.05186397DE
156-0.0291-40.64245810060.07160.09380.01351164580.05247942DE
260-0.0291-40.64245810060.07160.09380.01351164580.05247942DE
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TE9Teco 2030 ASA
0,04 €
(62,60%)
509,84k
1KPAProtara Therapeutics Inc
4,92 €
(46,43%)
1,97k
JJ8ASEP Medical Holdings Inc
0,049 €
(40,80%)
132,28k
2MCFirst Helium
0,025 €
(25,00%)
20,3k
4LN2Capricor Therapeutics Inc
14,72 €
(21,85%)
1,57k
YM4Raiden Resources Limited
0,005 €
(-47,37%)
1,02M
KASHIntellabridge Technology Corp
0,0155 €
(-40,38%)
1,2k
37NImagine Lithium Inc
0,006 €
(-36,84%)
5k
BLEBluebird bio Inc
0,4756 €
(-32,29%)
159,37k
BVU3St James Gold Corp
0,0635 €
(-31,72%)
500
D7GNel ASA
0,2632 €
(-1,61%)
3,13M
R9BDeFi Technologies Inc
3,515 €
(7,82%)
1,87M
AXIAtos SE
0,2633 €
(-16,41%)
1,54M
TUI1Tui AG
8,128 €
(2,86%)
1,41M
YM4Raiden Resources Limited
0,005 €
(-47,37%)
1,02M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock